Horseradish peroxidase-catalysed in situ-forming hydrogels for tissue-engineering applications

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 11, 2015, Pages 1225-1232

  Bae, Jin Woo ^a   Choi, Jong Hoon ^a   Lee, Yunki ^a   Park, Ki Dong ^a  

^a Ajou University   (South Korea)

Author keywords

Enzymatic crosslinking; Horseradish peroxidase; Hydrogen peroxide; in situ forming hydrogel; Phenol rich polymer; Tissue regeneration

Indexed keywords

CATALYSIS; CROSSLINKING; DEGRADATION; FOOD PRODUCTS; GELATION; HYDROGEN PEROXIDE; MEDICAL APPLICATIONS; OXIDATION; PHENOLS; TISSUE; TISSUE REGENERATION;

BIOMEDICAL APPLICATIONS; ENZYMATIC CROSSLINKING; HORSE-RADISH PEROXIDASE; IN SITU-FORMING HYDROGEL; IN-SITU FORMING; INJECTABLE HYDROGELS; MINIMALLY-INVASIVE SURGERY; PHENOL-RICH POLYMER; PROPERTY; TISSUE ENGINEERING APPLICATIONS;

HYDROGELS;

CHITOSAN; COLLAGENASE; FIBROBLAST GROWTH FACTOR 2; HORSERADISH PEROXIDASE; HYALURONIDASE; LYSOZYME; POLYMER; BIOMATERIAL; CROSS LINKING REAGENT; HYDROGEL; HYDROGEN PEROXIDE; PHENOL;

ADIPOSE DERIVED STEM CELL; BIODEGRADATION; BIOMEDICINE; CATALYSIS; CELL FUNCTION; CHEMICAL INTERACTION; CONCENTRATION (PARAMETERS); CROSS LINKING; DEGRADATION KINETICS; EXTRACELLULAR MATRIX; GELATION; HUMAN; HYDROGEL; MESENCHYMAL STEM CELL; MUSCLE REGENERATION; NONHUMAN; PHYSICAL PARAMETERS; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE SCAFFOLD; WOUND HEALING; ANIMAL; CARTILAGE; CHEMISTRY; CYTOLOGY; MOUSE; PATHOLOGY; PROCEDURES; RAT; REGENERATION; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; BIOCOMPATIBLE MATERIALS; CARTILAGE; CATALYSIS; CROSS-LINKING REAGENTS; HORSERADISH PEROXIDASE; HUMANS; HYDROGELS; HYDROGEN PEROXIDE; MICE; PHENOL; POLYMERS; RATS; REGENERATION; SIGNAL TRANSDUCTION; STEM CELLS; TISSUE ENGINEERING; WOUND HEALING;

EID: 84946499780     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1917     Document Type: Review

References (53)

1. Annabi N, Nichol JW, Zhong X, et al. 2010; Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue Eng B Rev 16: 371-383.
2. Banerjee A, Arha M, Choudhary S, et al. 2009; The influence of hydrogel modulus on the proliferation and differentiation of encapsulated neural stem cells. Biomaterials 30: 4695-4699.
3. Boateng JS, Matthews KH, Stevens HN, et al. 2008; Wound healing dressings and drug delivery systems: a review. J Pharm Sci 97: 2892-2923.
4. Brochhausen C, Lehmann M, Halstenberg S, et al. 2009; Signalling molecules and growth factors for tissue engineering of cartilage - what can we learn from the growth plate? J Tissue Eng Regen Med 3: 416-429.
5. Cao H, Liu T, Chew SY. 2009; The application of nanofibrous scaffolds in neural tissue engineering. Adv Drug Deliv Rev 61: 1055-1064.
6. Chan G, Mooney DJ. 2008; New materials for tissue engineering: towards greater control over the biological response. Trends Biotechnol 26: 382-392.
7. Choi JS, Harley BA. 2012; The combined influence of substrate elasticity and ligand density on the viability and biophysical properties of hematopoietic stem and progenitor cells. Biomaterials 33: 4460-4468.
8. Gilbert PM, Havenstrite KL, Magnusson KE, et al. 2010; Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science 329: 1078-1081.
9. Hunt NC, Grover LM. 2010; Cell encapsulation using biopolymer gels for regenerative medicine. Biotechnol Lett 32: 733-742.
10. Hwang JH, Kim IG, Piao S, et al. 2013; Combination therapy of human adipose-derived stem cells and basic fibroblast growth factor hydrogel in muscle regeneration. Biomaterials 34: 6037-6045.
11. Jin R, Hiemstra C, Zhong Z, et al. 2007; Enzyme-mediated fast in situ formation of hydrogels from dextran-tyramine conjugates. Biomaterials 28: 2791-2800.
12. Jin R, Moreira Teixeira LS, Dijkstra PJ, et al. 2010; Enzymatically crosslinked dextran-tyramine hydrogels as injectable scaffolds for cartilage tissue engineering. Tissue Eng A 16: 2429-2440.
13. Jin R, Moreira Teixeira LS, et al. 2011; Chondrogenesis in injectable enzymatically crosslinked heparin/dextran hydrogels. J Control Release 152: 186-195.
14. Kim DW, Jun I, Lee TJ, et al. 2013a; Therapeutic angiogenesis by a myoblast layer harvested by tissue transfer printing from cell-adhesive, thermosensitive hydrogels. Biomaterials 34: 8258-8268.
15. Kim BY, Bae JW, Park KD. 2013b; Enzymatically in situ shell crosslinked micelles composed of four-arm PPO-PEO and heparin for controlled dual drug delivery. J Control Release 172: 535-540.
16. Kim IL, Mauck RL, Burdick JA. 2011; Hydrogel design for cartilage tissue engineering: a case study with hyaluronic acid. Biomaterials 32: 8771-8782.
17. Klibanov AM, Alberti BN, Morris ED, et al. 1980; Enzymatic removal of toxic phenols and anilines from waste waters. J Appl Biochem 2: 414-421.
18. Ko DY, Shinde UP, Yeon B, et al. 2013; Recent progress of in situ formed gels for biomedical applications. Prog Polym Sci 38: 672-701.
19. Kobayashi S, Uyama H, Kimura S. 2001; Enzymatic polymerization. Chem Rev 101: 3793-3818.
20. Kurisawa M, Chung JE, Yang YY, et al. 2005; Injectable biodegradable hydrogels composed of hyaluronic acid-tyramine conjugates for drug delivery and tissue engineering. Chem Commun (Camb) 34: 4312-4314.
21. Lee BP, Dalsin JL, Messersmith PB. 2002; Synthesis and gelation of DOPA-modified poly(ethylene glycol) hydrogels. Biomacromolecules 3: 1038-1047.
22. Lee F, Chung JE, Kurisawa M. 2009; An injectable hyaluronic acid-tyramine hydrogel system for protein delivery. J Control Release 134: 186-193.
23. Lee HR, Park KM, Joung YK, et al. 2012a; Platelet-rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2. J Control Release 159: 332-337.
24. Lee HR, Park KM, Joung YK, et al. 2012b; Platelet-rich plasma loaded in situ-formed hydrogel enhances hyaline cartilage regeneration by CB1 upregulation. J Biomed Mater Res A 100: 3099-3107.
25. Lee K, Silva EA, Mooney DJ. 2011; Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 8: 153-170.
26. Lee Y, Bae JW, Oh DH, et al. 2013; In situ forming gelatin-based tissue adhesives and their phenolic content-driven properties. J Mater Chem B Mater Biol Med 1: 2407-2414.
27. Lih E, Lee JS, Park KM, et al. 2012; Rapidly curable chitosan-PEG hydrogels as tissue adhesives for hemostasis and wound healing. Acta Biomater 8: 3261-3269.
28. Lim TC, Toh WS, Wang LS, et al. 2012; The effect of injectable gelatin-hydroxyphenylpropionic acid hydrogel matrices on the proliferation, migration, differentiation and oxidative stress resistance of adult neural stem cells. Biomaterials 33: 3446-3455.
29. Lutolf MP, Gilbert PM, Blau HM. 2009; Designing materials to direct stem-cell fate. Nature 462: 433-441.
30. Moreira Teixeira LS, Bijl S, Pully VV, et al. 2012a; Self-attaching and cell-attracting in situ-forming dextran-tyramine conjugates hydrogels for arthroscopic cartilage repair. Biomaterials 33: 3164-3174.
31. Moreira Teixeira LS, Leijten JC, Wennink JW, et al. 2012b; The effect of platelet lysate supplementation of a dextran-based hydrogel on cartilage formation. Biomaterials 33: 3651-3661.
32. Nakamoto S, Machida N. 1992; Phenol removal from aqueous solutions by peroxidase-catalyzed reaction using additives. Water Res 26: 49-54.
33. Ogushi Y, Sakai S, Kawakami K. 2013; Adipose tissue engineering using adipose-derived stem cells enclosed within an injectable carboxymethylcellulose-based hydrogel. J Tissue Eng Regen Med 7: 884-892.
34. Park KM, Ko KS, Joung YK, et al. 2011; In situ cross-linkable gelatin-poly(ethylene glycol)-tyramine hydrogel via enzyme-mediated reaction for tissue regenerative medicine. J Mater Chem 21: 13180-13187.
35. Park KM, Lee Y, Son JY, et al. 2012a; Synthesis and characterizations of in situ crosslinkable gelatin and four-arm PPO-PEO hybrid hydrogels via enzymatic reaction for tissue regenerative medicine. Biomacromolecules 13: 604-611.
36. Park KM, Lee Y, Son JY, et al. 2012b; In situ SVVYGLR peptide conjugation into injectable gelatin-poly(ethylene glycol)-tyramine hydrogel via enzyme-mediated reaction for enhancement of endothelial cell activity and neovascularization. Bioconjug Chem 23: 2042-2050.
37. Park KM, Shin YM, Joung YK, et al. 2010; In situ-forming hydrogels based on tyramine conjugated four-arm PPO-PEO via enzymatic oxidative reaction. Biomacromolecules 11: 706-712.
38. Sakai S, Hirose K, Taguchi K, et al. 2009; An injectable, in situ enzymatically gellable, gelatin derivative for drug delivery and tissue engineering. Biomaterials 30: 3371-3377.
39. Sakurada J, Sekiguchi R, Sato K, et al. 1990; Kinetic and molecular orbital studies on the rate of oxidation of monosubstituted phenols and anilines by horseradish peroxidase compound II. Biochemistry 29: 4093-4098.
40. Spiller KL, Maher SA, Lowman AM. 2011; Hydrogels for the repair of articular cartilage defects. Tissue Eng B Rev 17: 281-299.
41. Moreira Teixeira LS, Feijen J, van Blitterswijk CA, et al. 2012; Enzyme-catalyzed crosslinkable hydrogels: emerging strategies for tissue engineering. Biomaterials 33: 1281-1290.
42. Toh WS, Lim TC, Kurisawa M, et al. 2012; Modulation of mesenchymal stem cell chondrogenesis in a tunable hyaluronic acid hydrogel microenvironment. Biomaterials 33: 3835-3845.
43. Tong Z, Qingxiang Z, Hui H, et al. 1997; Removal of toxic phenol and 4-chlorophenol from waste water by horseradish peroxidase. Chemosphere 34: 893-903.
44. Tran NQ, Joung YK, Lih E, et al. 2011; In situ-forming and rutin-releasing chitosan hydrogels as injectable dressings for dermal wound healing. Biomacromolecules 12: 2872-2880.
45. Tran NQ, Joung YK, Lih E, et al. 2010; Supramolecular hydrogels exhibiting fast in situ gel-forming and adjustable degradation properties. Biomacromolecules 11: 617-625.
46. Trappmann B, Gautrot JE, Connelly JT, et al. 2012; Extracellular matrix tethering regulates stem cell fate. Nat Mater 11: 642-649.
47. Tse JR, Engler AJ. 2011; Stiffness gradients mimicking in vivo tissue variation regulate mesenchymal stem cell fate. PLoS One 6: e15978.
48. Veitch NC. 2004; Horseradish peroxidase: a modern view of a classic enzyme. Phytochemistry 65: 249-259.
49. Wang LS, Boulaire J, Chan PP, et al. 2010a; The role of stiffness of gelatin-hydroxyphenylpropionic acid hydrogels formed by enzyme-mediated crosslinking on the differentiation of human mesenchymal stem cells. Biomaterials 31: 8608-8616.
50. Wang LS, Chung JE, Chan PP, et al. 2010b; Injectable biodegradable hydrogels with tunable mechanical properties for the stimulation of neurogenesic differentiation of human mesenchymal stem cells in 3D culture. Biomaterials 31: 1148-1157.
51. Wang LS, Chung JE, Kurisawa M. 2012; Controlling fibroblast proliferation with dimensionality-specific response by stiffness of injectable gelatin hydrogels. J Biomater Sci Polym Ed 23: 1793-1806.
52. Xu K, Lee F, Gao SJ, et al. 2013; Injectable hyaluronic acid-tyramine hydrogels incorporating interferon-α2a for liver cancer therapy. J Control Release 166: 203-210.
53. Ye Z, Zhou Y, Cai H, et al. 2011; Myocardial regeneration: roles of stem cells and hydrogels. Adv Drug Deliv Rev 63: 688-697.